Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Robot-assisted sutureless partial nephrectomy for the treatment of fifteen bilateral renal masses in a patient with Von Hippel-Lindau syndrome: a case report from a high-volume robotic center.
Peraire Lores M, Domínguez J, Bravi CA, Mottaran A, Sarchi L, Paciotti M, Piro A, Nocera L, Balestrazzi E, Farinha R, Pauwaert K, Van Herwaarden M, Vinckier MH, De Backer P, De Groote R, D'Hondt F, De Naeyer G, Mottrie A. Peraire Lores M, et al. Among authors: paciotti m. CEN Case Rep. 2023 Aug;12(3):335-340. doi: 10.1007/s13730-022-00770-7. Epub 2023 Jan 7. CEN Case Rep. 2023. PMID: 36611089 Free PMC article.
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study.
Fasulo V, Buffi NM, Regis F, Paciotti M, Persico F, Maffei D, Uleri A, Saita A, Casale P, Hurle R, Lazzeri M, Guazzoni G, Lughezzani G. Fasulo V, et al. Among authors: paciotti m. World J Urol. 2022 Feb;40(2):435-442. doi: 10.1007/s00345-021-03890-4. Epub 2022 Jan 10. World J Urol. 2022. PMID: 35001161
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure.
Hurle R, Contieri R, Casale P, Morenghi E, Saita A, Buffi N, Lughezzani G, Colombo P, Frego N, Fasulo V, Paciotti M, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: paciotti m. Urol Oncol. 2021 Mar;39(3):195.e7-195.e13. doi: 10.1016/j.urolonc.2020.09.017. Epub 2020 Oct 23. Urol Oncol. 2021. PMID: 33268275
Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD, Paciotti M, Marchese M, Cole AP, Cone EB, Kibel AS, Ortega G, Lipsitz SR, Weissman JS, Trinh QD. Nguyen DD, et al. Among authors: paciotti m. JCO Oncol Pract. 2021 May;17(5):e654-e665. doi: 10.1200/OP.21.00010. JCO Oncol Pract. 2021. PMID: 33974827
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study.
Lughezzani G, Maffei D, Saita A, Paciotti M, Diana P, Buffi NM, Colombo P, Elefante GM, Hurle R, Lazzeri M, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: paciotti m. Eur Urol Focus. 2021 Sep;7(5):1019-1026. doi: 10.1016/j.euf.2020.09.013. Epub 2020 Oct 15. Eur Urol Focus. 2021. PMID: 33069624
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic.
Tan WS, Marchese M, Paciotti M, Nguyen DD, Cone EB, Mossanen M, Webster JJ, Barod R, Bex A, Kibel AS, Chang SL, Trinh QD. Tan WS, et al. Among authors: paciotti m. Minerva Urol Nephrol. 2021 Jun;73(3):404-406. doi: 10.23736/S2724-6051.20.04197-1. Epub 2021 Mar 29. Minerva Urol Nephrol. 2021. PMID: 33781018 Free article. No abstract available.
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.
Klotz L, Lughezzani G, Maffei D, Sánchez A, Pereira JG, Staerman F, Cash H, Luger F, Lopez L, Sanchez-Salas R, Abouassaly R, Shore ND, Eure G, Paciotti M, Astobieta A, Wiemer L, Hofbauer S, Heckmann R, Gusenleitner A, Kaar J, Mayr C, Loidl W, Rouffilange J, Gaston R, Cathelineau X, Klein E. Klotz L, et al. Among authors: paciotti m. Can Urol Assoc J. 2021 Jan;15(1):E11-E16. doi: 10.5489/cuaj.6712. Can Urol Assoc J. 2021. PMID: 32701437 Free PMC article.
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.
Fasulo V, Paciotti M, Lazzeri M, Contieri R, Casale P, Saita A, Lughezzani G, Diana P, Frego N, Avolio PP, Colombo P, Elefante GM, Guazzoni G, Buffi NM, Bates M, Hurle R. Fasulo V, et al. Among authors: paciotti m. Front Oncol. 2022 Jan 27;12:832835. doi: 10.3389/fonc.2022.832835. eCollection 2022. Front Oncol. 2022. PMID: 35155263 Free PMC article.
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.
Contieri R, Lughezzani G, Buffi NM, Taverna G, Giacobbe A, Micheli E, Barra S, Colombo P, Vanni E, Guazzoni G, Lazzeri M, Hurle R; HuNIRe Study Group. Contieri R, et al. Front Oncol. 2022 May 18;12:879399. doi: 10.3389/fonc.2022.879399. eCollection 2022. Front Oncol. 2022. PMID: 35664755 Free PMC article.
116 results